Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):201. doi: 10.1158/1055-9965.EPI-09-0569

Table 2.

Mammography Screening Adherence and Forward Movement in Stage of Screening Adoption by Group at 6 Month Follow-up

Intervention
n=89
Comparison
n=90
Relative risk (95% CI)
Odds ratio (95% CI)
p value

n % n %
Adherence at 6 months (medical record verified) 45 50.6 16 17.8 2.8 (1.7, 4.6) <.0001
4.7 (2.4, 9.4) <.0001
Stage changes <.0001
 -2 (went back 2 stages) 0 0 1 1.5
 -1 (Went back 1 stage) 2 2.5 7 10.8
 0 (Stayed the same) 17 21.3 32 49.2
 1(Moved forward 1 stage) 14 17.5 8 12.3
 2 (Moved forward 2 stages) 46 57.5 17 26.2
 3 (Moved forward 3 stages) 1 1.3 0 0
Forward stage movement at 6 month interview 61 76.3 25 38.5 2.0 (1.4, 2.8) <.0001
5.1 (2.5, 10.5) <.0001

Note: p-value for Stage change is from two-sided Fisher exact test for collapsed variable into three categories (-2/-1/0 vs. 1 vs. 2/3). P value for forward stage movement is for forward (1, 2, 3) vs backward or stay the same, regarding stage change from baseline to 6 month interview (-2/-1/0). The sample size for stage changes at 6 months (T3) are Intervention (n=80) and Usual Care (n=65).